Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$12.15 +0.41 (+3.45%)
As of: Sep 30, 2026 · 11:34 AM EDT

Monte Rosa Therapeutics (GLUE) Total Current Liabilities (2020 - 2026)

Updated

Monte Rosa Therapeutics (GLUE) recorded Total Current Liabilities of $59.66 million in Q2 2026, up 42.5% from $41.85 million a year earlier but down 16.0% from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Monte Rosa Therapeutics reported Total Current Liabilities of $64.21 million, down 59.1% from FY2024.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of 17.0% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $156.95 million in FY2024 (+236.9%), $46.59 million in FY2023 (+82.2%), $25.57 million in FY2022 (+53.7%) and $16.64 million in FY2021 (-43.2%).
  • Quarterly Total Current Liabilities has ranged from $12.49 million in Q1 2022 to $156.95 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Total Current Liabilities rose in six of the last eight quarters, with growth averaging 51.8%.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 236.9% in Q4 2024, against a decline of 59.1% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $71.04 million (Q1 2026), $64.21 million (Q4 2025) and $61.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Monte Rosa Therapeutics 998.00 Mn 409.81 Mn - 59.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.66 Mn
Mar 31, 2026 71.04 Mn
Dec 31, 2025 64.21 Mn
Sep 30, 2025 61.44 Mn
Jun 30, 2025 41.85 Mn
Mar 31, 2025 59.22 Mn
Dec 31, 2024 156.95 Mn
Sep 30, 2024 41.64 Mn
Jun 30, 2024 42.35 Mn
Mar 31, 2024 41.29 Mn
Dec 31, 2023 46.59 Mn
Sep 30, 2023 22.61 Mn
Jun 30, 2023 19.09 Mn
Mar 31, 2023 20.52 Mn
Dec 31, 2022 25.57 Mn
Sep 30, 2022 21.79 Mn
Jun 30, 2022 14.77 Mn
Mar 31, 2022 12.49 Mn
Dec 31, 2021 16.64 Mn
Sep 30, 2021 12.74 Mn
API Access

Monte Rosa Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=GLUE&period=max&api_key=YOUR_API_KEY